Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesynib: Imatinib + DHA-PPQ for Malaria
NCT03697668Phase 2Unknown
- Start
- Sep 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in Plasmodium falciparum malaria. Status: unknown.
02
Drugs
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT03697668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03697668.